United States
Germany
Japan
United Kingdom
China
Anti-MAP2K2 (MEK2 ) mouse monoclonal antibody, clone OTI8G6 (formerly 8G6)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
热销推荐
Products
MAP2K2 (MEK2 ) mouse monoclonal antibody, clone OTI1A2 (formerly 1A2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
热销推荐
CNY 3,990.00
2周
CNY 3,990.00
2周
Anti-MAP2K2 (MEK2 ) mouse monoclonal antibody, clone OTI8G6 (formerly 8G6)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 3,990.00
2周
CNY 3,990.00
2周
Anti-MAP2K2 (MEK2 ) mouse monoclonal antibody, clone OTI5F6 (formerly 5F6)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
MAP2K2 (MEK2 ) mouse monoclonal antibody, clone OTI5B4 (formerly 5B4)
| Applications | IF, WB |
| Reactivities | Human, Dog, Mouse, Rat |
热销推荐
CNY 3,990.00
2周
CNY 3,990.00
2周
MAP2K2 (MEK2 ) mouse monoclonal antibody, clone OTI5G8 (formerly 5G8)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
热销推荐
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Reactivities
Antibody Hosts
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Brands
Families
Pathways
- Acute myeloid leukemia (33)
- B cell receptor signaling pathway (33)
- Bladder cancer (33)
- Chronic myeloid leukemia (33)
- Endometrial cancer (33)
- ErbB signaling pathway (33)
- Fc epsilon RI signaling pathway (33)
- Gap junction (33)
- Glioma (33)
- GnRH signaling pathway (33)
- Insulin signaling pathway (33)
- Long-term depression (33)
- Long-term potentiation (33)
- MAPK signaling pathway (33)
- Melanogenesis (33)
- Melanoma (33)
- Natural killer cell mediated cytotoxicity (33)
- Neurotrophin signaling pathway (33)
- Non-small cell lung cancer (33)
- Pathways in cancer (33)
- Prion diseases (33)
- Prostate cancer (33)
- Regulation of actin cytoskeleton (33)
- Renal cell carcinoma (33)
- T cell receptor signaling pathway (33)
- Thyroid cancer (33)
- Toll-like receptor signaling pathway (33)
- VEGF signaling pathway (33)
- Vascular smooth muscle contraction (33)
